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Although crucial for their correct function, the mechanisms controlling surface expression
of ion channels are poorly understood. In the case of the voltage-gated potassium channel
KV10.1, this is determinant not only for its physiological function in brain, but also for its
pathophysiology in tumors and possible use as a therapeutic target. The Golgi resident
protein PIST binds several membrane proteins, thereby modulating their expression. Here
we describe a PDZ domain-mediated interaction of KV10.1 and PIST, which enhances
surface levels of KV10.1. The functional, but not the physical interaction of both proteins
is dependent on the coiled-coil and PDZ domains of PIST; insertion of eight amino acids
in the coiled-coil domain to render the neural form of PIST (nPIST) and the corresponding
short isoform in an as-of-yet unknown form abolishes the effect. In addition, two new
isoforms of PIST (sPIST and nsPIST) lacking nearly the complete PDZ domain were cloned
and shown to be ubiquitously expressed. PIST and KV10.1 co-precipitate from native
and expression systems. nPIST also showed interaction, but did not alter the functional
expression of the channel. We could not document physical interaction between KV10.1
and sPIST, but it reduced KV10.1 functional expression in a dominant-negative manner.
nsPIST showed weak physical interaction and no functional effect on KV10.1. We propose
these isoforms to work as modulators of PIST function via regulating the binding on
interaction partners.
Keywords: potassium channels, KV10.1, KCNH1, PIST, FIG, GOPC, trafficking
INTRODUCTION
The voltage gated potassium channel KV10.1 is the founding
member of the family of ether à go-go channels (Warmke and
Ganetzki, 1994). The function of this ion channel in the cen-
tral nervous system, where it is normally exclusively expressed,
still remains elusive (Occhiodoro et al., 1998; Pardo et al.,
1999). Ectopically expressed KV10.1 induces a transformed phe-
notype, and the channel is expressed in 70% extra-cranial tumors
(Hemmerlein et al., 2006; Mello De Queiroz et al., 2006; Ding
et al., 2007a,b, 2008; Ousingsawat et al., 2007; Wadhwa et al.,
2009; Agarwal et al., 2010; Asher et al., 2010). Although there is
evidence pointing to an additional non-canonical, permeation-
independent role of the channel in cancer initiation and growth
(Downie et al., 2008; Chen et al., 2011), inhibition of channel
function exclusively at the plasma membrane by a monoclonal
antibody (Gomez-Varela et al., 2007) reduces tumor progression
in vivo, indicating that themembrane population of the channel is
very important for its oncogenic properties. However, the mech-
anisms regulating the expression of KV10.1 at the surface are still
unclear, although it is known that the membrane residence time
of the channel is relatively short, because it is internalized at a rate
of 2% per minute (Kohl et al., 2011), and that both rabaptin 5 and
cortactin are important to determine the abundance of KV10.1
at the plasma membrane at a given time(Herrmann et al., 2012;
Ninkovic et al., 2012).
PIST (PDZ domain protein interacting specifically with
TC10), also called GOPC (Golgi-associated PDZ and coiled-coil
motif-containing protein), CAL (CFTR-associated ligand) or FIG
(fused in glioblastoma) was first described in 2001 as a coiled-coil
and PDZ domain-containing protein that specifically interacts
with the GTPase TC10 (Neudauer et al., 2001). Depending on
one of its coiled-coil regions, PIST mainly resides in the Golgi
apparatus, but can also co-localize with its binding partners at the
plasma membrane (Charest et al., 2001; Yao et al., 2001; Wente
et al., 2005b). Many studies have addressed the possible inter-
action partners of PIST, in order to unravel the function of this
protein. Proteins known to be located at the trans-Golgi network
(TGN) like Syntaxin 6 or Golgin160 are able to bind the coiled-
coil region of PIST, pointing to an involvement of this protein in
processes like TGN sorting and vesicle trafficking (Charest et al.,
2001; Hicks and Machamer, 2005). A crystal structure of this
domain of PIST is available (Shin et al., 2013). The ability of PIST
to bind activated small GTPases like TC10 and Rab6amay serve as
a mechanism controlling PIST function in response to signaling
pathways, as shown for cystic fibrosis transmembrane conduc-
tance regulator (CFTR) (Neudauer et al., 2001; Cheng et al., 2005;
Bergbrede et al., 2009). Most other interaction partners of PIST
are reported to bind to its PDZ domain, among them CFTR itself
(Cheng et al., 2002), the G-protein-coupled receptors frizzled 5
and 8 (Yao et al., 2001), the chloride channel CIC-3B (Gentzsch
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et al., 2003), the β1-adrenergic receptor (He et al., 2004), the
somatostatin receptor subtype 5 [SSTR5 (Wente et al., 2005b)], a
metabotropic glutamate receptor [mGluR1a, (Zhang et al., 2008)]
and Cadherin 23 (Xu et al., 2010). Several studies discuss that
overexpression of PIST might lead to different surface expression
patterns of some of these membrane proteins by holding them
back in the Golgi (He et al., 2004; Wente et al., 2005b; Xu et al.,
2010). A different and more detailed process is postulated for
CFTR, where PIST enhances degradation by facilitating its target-
ing to lysosomes (Cheng et al., 2005). A fusion between PIST and
the proto-oncogene ROS1 has been detected, initially in glioblas-
toma and subsequently in other cancer types (Charest et al., 2003;
Birch et al., 2011; Gu et al., 2011; Suehara et al., 2012).
Relevant functions of PIST in the brain appear to be medi-
ated by an alternatively spliced isoform (nPIST) that contains an
eight amino acid insertion in the second coiled-coil region (Yue
et al., 2002). This isoform is able to interact with Beclin1 over
its coiled-coil domain and therefore was linked to autophagy in
neurons of lurcher mice (Yue et al., 2002), although constitutive
ion fluxes were able to induce cell death regardless of the nPIST-
Beclin1 interaction (Nishiyama et al., 2010). Additionally, gluta-
mate receptors are able to bind to the PDZ domain of nPIST over
their extreme C-terminus (Yue et al., 2002; Cuadra et al., 2004).
This interaction in concert with Stargazin has been shown to
enhance synaptic clustering of AMPA receptors in hippocampal
neurons (Cuadra et al., 2004).
In this study, we identified PIST as a new interaction part-
ner of KV10.1. We show physical as well as functional interaction
between PIST and KV10.1. We were also able to identify and clone
two new isoforms of PIST, and provide evidence that the four
isoforms of PIST differ in terms of binding to and regulation of
KV10.1.
MATERIALS AND METHODS
YEAST TWO-HYBRID
The yeast reporter strain L40 (Vojtek et al., 1993) (MATa, trp1,
leu2, his3, LYS::lexA-HIS3, URA3::lexA-lacZ) was transformed
with pLexN-hEag1 by the lithium acetate method and grown
on synthetic medium lacking tryptophan. After additional trans-
formation with plasmid pVP16-3-cDNA [postnatal 8 rat brain
cDNA library, (Okamoto and Sudhof, 1997)], double transfor-
mants were plated on syntheticmedium lacking histidine, leucine,
uracil, lysine, tryptophan and in the presence of the competi-
tive inhibitor of the HIS3 protein 3-amino-1,2,4-triazole (3-AT).
Positive colonies were picked after 4–6 days and tested for ß-
galactosidase activity using plate assay. Plasmids from positive
clones were rescued and transformed in E. coli strain HB101.
E. coli cells were plated on leucine-lacking medium. Positive
clones were further analyzed by yeast retransformation and DNA
sequencing.
RNA PURIFICATION, cRNA SYNTHESIS AND RT-PCR
HEK 293 cells were washed 3 times with ice cold PBS, harvested
and directly used for RNA purification using RNAeasy Mini Kit
(Qiagen). First strand cDNA was produced using SuperScript
(Invitrogen) with oligo-dT. For cloning, PIST was amplified in
a standard PCR reaction using Taq DNA polymerase (NEB)
and sense and antisense primers (see below). PCR products
were analyzed by electropohoresis, fragments excised out of gel
and purified using NucleoSpin Extract (Macherey-Nagel) and
subcloned in pGEMT-easy (Promega) following manufacturer’s
instructions.
Mouse first strand cDNA was a generous gift from Dr. R.
Ufartes (Ufartes et al., 2013).
To distinguish between isoforms, PCR products were obtained
in a standard PCR procedure using 100 ng cDNA mouse first
strand cDNA, and a set of 2 or 3 specific primers in the appro-
priate combinations to distinguish between isoforms (see below)
and Biotherme Polymerase (Genecraft).
Primers for human PIST (accession numbers
NM_001017408.2—PIST- and NM_020399.3—sPIST-) were:
5′ ATGTCGGCGGGCGGTCCATGC3′ and
5′TTAATAAGATTTTTTATGATACAGAG3′
For mouse PIST (accession numbers NM_001199272.1 and
NM_053187.3):
5′GCAGAGGGCGCAACGACTT3′ and
5′ATTCTCATGCGCATCCCTCACTG3′
For selective amplification of the previously described tran-
script variants, we used different forward primers (nPIST;
NM_020399.3: 5′ CAAGGCAAAATTGTCTGTCCAC 3′; PIST,
NM_001017408.2: 5′ CAAGGCAAAATTGGAAAGAGAAC 3′),
and to distinguish between short and long forms, the following
antisense primers were used:
Short 5′ CTCTCTGCTGGGAGAGTATAG 3′
Long 5′ CTCTCCTCTCTGTGTGATAGA 3′
CELL CULTURE AND TRANSFECTION
HeLa cells were cultured in MEM+GlutaMax (Invitrogen)
supplemented with 10% FCS (PAA), HEK293 cells in
DMEM/F12+GlutaMax (Invitrogen) supplemented with
10% FCS and for stable cell line HEK293-KV10.1-BBS [HEK-
BBS, (Kohl et al., 2011)] with Zeocin (Invitrogen) at 5% CO2 and
37◦C.
Transfection was performed using Lipofectamine 2000 or
Lipofectamine (Invitrogen) according to the manufacturer’s
instructions. KV10.x-BBS Venus and CFP-PISTwere generated by
cloning into pcDNA3 or pECFP-N1 vectors. Empty vectors were
used as controls.
FRACTIONAL LABELING, QUANTIFICATION AND PURIFICATION OF
KV10.1-BBS
Labeling of whole-cell KV10.1-BBS was performed in cell
lysates in buffer LP [20mM Tris-HCl pH 7.4, 150mM NaCl,
5mM MgCl2, 1% Nonidet P40, protease inhibitors (Roche)]
with α-bungarotoxin (BTX)-biotin conjugate (Invitrogen) in a
final concentration of 0.2μg/ml for 30min on ice. To detect
membrane and/or internalized KV10.1-BBS, transfected HEK-
BBS cells were incubated in media supplemented with α-
BTX-biotin conjugate (Invitrogen) in a final concentration of
2.5μg/ml and kept at room temperature for 10min (mem-
brane) or at 37◦C for one hour (internalized). For internal-
ized KV10.1-BBS, cells were washed with ice-cold acid wash
buffer (150mM NaCl, pH 3.0) for 3min to remove mem-
brane labeling of KV10.1-BBS. Twice washing with cold PBS
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removed residual α-BTX-biotin conjugate. Cells were then har-
vested and lysed with LP buffer for 20min on ice. Insoluble
fraction was removed by centrifugation at 18,000 × g at
4◦C, and the supernatant used for ELISA or pull down
experiments.
For pull down approaches, labeled KV10.1-BBS was bound
on streptavidin-coated magnetic beads (T1, Invitrogen) for 2 h
at 4◦C. Unbound protein was removed by washing 5 times with
buffer LP supplemented with protease inhibitors (Roche). Bound
protein was eluted at 70◦C for 10min using LDS sample buffer
containing reducing agent (Invitrogen) and analyzed by SDS
PAGE (Invitrogen) and western blotting.
Quantification of the amount of labeled KV10.1-BBS was per-
formed by ELISA. After labeling, total cell lysates (30 and 150μg
protein), were immobilized on streptavidin-coated plates (Pierce)
and detected using a C-terminal monoclonal anti-KV10.1 anti-
body [Ab33, 5μg/ml (Hemmerlein et al., 2006)] and a polyclonal
anti-mouse secondary antibody (Pierce, 1:500) coupled to perox-
idase. ABTS (Invitrogen) was used as a substrate for development
and detected in a Wallac Victor2 reader at 405 nm (reference
490 nm). Experiments were performed in duplicates.
PULL DOWN EXPERIMENTS
For immunoprecipitation, rat brain lysates (800μg total protein)
were incubated overnight at 4◦C with 2–5μg of antibody [anti-
KV10.1 33/62 (Hemmerlein et al., 2006); anti-PIST (Millipore);
non-specific mouse IgGκ2b) in buffer A (0,5% Triton X-100,
25mM TrisHCl pH7.5, 75mM NaCl, 2.5mM EDTA and pro-
tease inhibitors (Roche)]. Pull down was performed by adding
20μl of Protein G/A-coated Sepharose beads (Calbiochem) for
2 h at 4◦C under rotation. After washing five times with buffer
A, bound protein was eluted at 70◦C for 10min using LDS sam-
ple buffer containing reducing agent (Invitrogen) and analyzed by
SDS PAGE (Invitrogen) and western blotting.
ELECTROPHYSIOLOGY
Recordings on Xenopus oocytes were performed as described
by Stuhmer (1998) using a Turbo TEC-10CD amplifier (NPI
electronics). cRNA was synthesized using the mMessage mMa-
chine kit (Ambion) according to the manufacturer’s instruc-
tions. 0.1–1 ng cRNA per oocyte were microinjected 1–3 days
prior to recording. Cells were kept at 18◦C in ND 96 solution
(96mM NaCl, 2mM KCl, 0.2mM CaCl2, 2mM MgCl2, 5mM
Hepes/NaOH, pH 7.5) supplemented with theophylline (0.5mM)
to avoid maturation of the oocytes. For voltage clamp record-
ings, pipettes had resistances ranging from 0.5 to 1.2M when
filled with 2M KCl. External solution (NFR) contained 115mM
NaCl, 2.5mM KCl, 1.8mM CaCl2, 10mM Hepes/NaOH, pH 7.2.
Current was digitized at 5 kHz and filtered at 1 kHz. Currents
were elicited by 1 s depolarizations from a holding potential of
−100mV to values ranging from +80 to −100mV. Current
amplitude was determined as mean value in the last 200ms of
the depolarization. To fit current-voltage relationships, we used
an equation of the form:
I(V) =  · (V − Vrev)(
1 + e V50−Vk
)4
where  is the total conductance, Vrev the reversal potential,
V50 the potential of half activation per subunit and k the slope
factor.
Data acquisition and analysis was performed with Pulse-
PulseFit (HEKA Electronics) and IgorPro (WaveMetrics).
MICROSCOPY
For confocal microscopy, HeLa cells were grown on glass cov-
erslips and transfected with Venus-tagged KV10.1 and CFP-
tagged isoforms of PIST. Empty vectors served as control. 24 h
after transfection, the Golgi marker BODIPY FL C5 Ceramide
(Invitrogen) was used according to manufacturer’s instructions to
visualize Golgi apparatus. Cells were fixed in 4% paraformalde-
hyde in PBS for 10min at room temperature, washed thor-
oughly with HBBS and mounted with ProLong Gold Antifade
Reagent (Invitrogen). Image acquisition was performed using
a Zeiss LSM 510 Meta confocal microscope with a Zeiss 40x
1.2 Korr water immersion objective. Single channel gray scale
images are presented using color tables according to the fluo-
rophore used. Merged images were generated by combination
of the channel images into a single RGB file. Only linear con-
trast enhancement and Gaussian blur were applied off-line to
the images; analysis was carried out with Fiji (Schindelin et al.,
2012).
RESULTS
PIST INTERACTSWITH THE VOLTAGE-GATED ION CHANNEL KV10.1
Finding new interaction partners of KV10.1is crucial to unravel
the role of this ion channel both in the healthy brain and in
tumors. To identify candidate interaction partners of KV10.1,
we performed yeast two-hybrid screens using a rat brain
expression library. The C-terminus of KV10.1 in fusion to
the DNA binding domain of LexA transcription factor was
used as a bait to screen a rat brain cDNA library fused to
the activation domain of VP16 transcription factor. As pre-
viously reported (Ninkovic et al., 2012), out of 2 million
screened clones, eight were positive for the HIS3 marker. One
of them encoded most of the open reading frame of the
murine PIST, including its PDZ domain (Neudauer et al.,
2001).
We then performed co-immunoprecipitation studies to con-
firm the interaction. Precipitation of PIST using a specific anti-
body was able to pull down KV10.1 out of rat brain lysates
(Figure 1A). In reverse co-IP experiments, PIST co-precipitated
KV10.1 (Figure 1B). Non-specific isotype antibodies did not pre-
cipitate either of the two proteins.
In a second pull-down approach we used HEK293 cells stably
expressing a modified KV10.1 bearing an α-bungarotoxin (BTX)
binding site [KV10.1_BBS, (Kohl et al., 2011)]. Specific binding
of a BTX-biotin conjugate to its binding site allows precipitation
of KV10.1_BBS from cell lysates. After transfection with CFP-
labeled PIST, pull down of KV10.1_BBS with BTX-biotin and
immunoblotting using anti-PIST antibodies revealed two bands
compatible with endogenous PIST as well as CFP-labeled PIST
(Figure 1C, lane+Bb); no bands were detected if BTX-biotin was
omitted (Figure 1C, lane −Bb). The fact that both endogenous
andCFP-tagged PIST are detected argues in favor of the specificity
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FIGURE 1 | Co-precipitation of KV10.1 and PIST out of (A,B) rat brain
lysates and (C) HEK293_KV10.1_BBS cells. Specific antibodies against
PIST (A) or KV10.1 (B) were used for precipitation out of rat brain lysates
using Protein A/G coupled sepharose beads. Isotype control antibodies
served as negative controls. Co-precipitation of Kv10.1 by anti PIST
immunoprecipitation (A) as well as precipitation of PIST by anti KV10.1
immunoprecipitation (B) were detected by western blot. (C) KV10.1_BBS
was labeled with an α-bungarotoxin-biotin conjugate after lysis of
HEK293_KV10.1_BBS cells and pulled down with streptavidin-coated beads.
Detection on a western blot with and anti-PIST antibody shows bands
compatible with precipitation of both CFP-tagged and endogenous PIST.
of PIST detection. As a control, the same experiments using
unlabeled KV10.1_BBS did not precipitate PIST, also indicating
specificity of the co-IP. Taken together, these results strongly indi-
cate that PIST and KV10.1 interact physically both in vitro and
in vivo.
TWO NEW SHORT PIST ISOFORMS LACKING THE PDZ DOMAIN ARE
EXPRESSED IN ALL TISSUES TESTED
For further analysis we amplified and cloned the human PIST
out of cDNA obtained from untransfected HEK293 cells, using
5′ and 3′ flanking primers. Interestingly, during the cloning pro-
cess we systematically observed two bands, one of them at the
expected size of full length PIST and a shorter one. Cloning
and subsequent sequencing of the shorter band revealed that
it corresponds to a PIST variant lacking the complete exon
6, which is the region coding for the majority of the PDZ
domain indicating that this clone corresponds to a new splice
variant of PIST. To further proof the existence of the new iso-
form, we designed primers to generate an amplicon containing
the skipped exon, in order to discriminate between the longer
and the shorter form of PIST. We were able to amplify frag-
ments with the expected sizes out of cDNA from HEK293
cells (data not shown). To evaluate the tissue distribution of
the splice variant we used mouse cRNA from different tissues.
The variant (lacking in the mouse exon 5) was detected in all
FIGURE 2 | New PIST isoforms. (A) PCR on cDNA from different mouse
tissues show amplification of short (205bp) and a long (408bp) fragments
corresponding to sPIST and PIST. (B) A PCR designed to differentiate
neuronal and non-neuronal forms of PIST detect both short and long bands
revealing the widely extended expression of both forms. (C) Schematic
representation of the domains of all four PIST isoforms. Coiled-coil regions
are depicted in orange, the insertion in n-PISTs in the second coiled-coil is
represented in blue. The PDZ domain is represented in green, and a vertical
line represents the site of deletion of exon 6.
tissues tested except pancreas, where amplification of full-length
PIST was also much weaker (Figure 2A). The signals for the
short form were consistently weaker than those for full-length
PIST.
In 2002, a second isoform of PIST was cloned and termed
“neuronal PIST” (nPIST) because it is believed to be the main
form in the brain. It differs from PIST by an 8 amino acid inser-
tion in the coiled-coil region (Yue et al., 2002). The sequence
we identified here codes for a protein that lacks the main part
of the PDZ domain but bears the 8 amino acids of the neu-
ronal form. We therefore asked if there is a fourth isoform,
lacking the PDZ as well as the 8 amino acid insertion. PCR
with primer pairs distinguishing between nPIST and PIST and
producing different fragment length depending on the pres-
ence of the alternatively skipped exon was used to answer this
question. Amplification of the expected fragments out of cDNA
from HEK293 cells as well as from different murine tissues indi-
cated that all four isoforms are expressed in nearly every tissue
(Figure 2B). Weak or absent expression of nPIST in liver and pan-
creas correlated with no detection of the short form (nsPIST)
of it, indicating that expression of the shorter form depends on
the expression of the corresponding longer one (Figure 2B). The
cartoon in Figure 2C depicts the domain structure of the four
PIST isoforms. Taken together, our data suggests that two new
short forms of PIST (from here on termed sPIST and nsPIST)
exist and are expressed in nearly every tissue. According to our
semi-quantitative approach, both seem to be less abundant than
their corresponding longer form. sPIST and nsPIST sequences
have been deposited under accession numbers KF420122 and
KF420123, respectively.
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SHORT AND LONG ISOFORMS OF PIST HAVE DIFFERENT CAPABILITIES
FOR BINDING TOKV10.1
PIST is known to form homodimers depending on the second
coiled-coil motif, which bears also a leucine zipper (Neudauer
et al., 2001). As this region is intact in every identified isoform,
we tested if the shorter variants can form heterodimers with the
longer ones. To this end, we transfected CFP-labeled PIST con-
structs and used a GFP-specific antibody to immunoprecipitate
the extracts that were subsequently blotted using a PIST-antibody.
Precipitation of CFP-tagged PIST and nPIST co-precipitated a
band compatible with endogenous PIST (or nPIST), strongly
suggesting that dimerization of PIST occurs in our system
(Figure 3A). The major band that co-immunoprecipitated with
CFP-tagged nsPIST was smaller than the one pulled by full-length
forms and compatible with the size of an endogenous short iso-
form, suggesting that the short isoforms (or at least nsPIST) do
occur at the protein level in vivo. Expression of sPIST-CFP was
not clearly detectable even after immunoprecipitation, render-
ing interpretation of the results difficult with this isoform, even
though an endogenous band was detected. We therefore excluded
sPIST from transfection-based experiments and concentrated on
the other three variants.
We cannot exclude formation of heterodimers between nPIST
and PIST isoforms, because HEK293 cells express all four iso-
forms of PIST and in this approach we cannot resolve the eight
residues difference between PISTs and nPISTs.
FIGURE 3 | (A) Heteromerization of long and short forms of PIST. (A) GFP
antibody was used to precipitate CFP-tagged PIST isoforms out of lysates
of transfected HEK293 cells. PIST isoforms were detected using a
polyclonal antibody against PIST. Bands compatible with both the
GFP-tagged forms and with endogenous PIST were detected, indicating
association between the transfected CFP-PIST and the endogenous one.
(B) Co-precipitation of PIST isoforms with KV10.1_BBS. Lysates of
KV10.1_BBS-expressing cells were labeled with an α-BTX-biotin conjugate
and pulled down with streptavidin-coated beads (see Figure 1). Anti-PIST
specific antibodies detected co-immunoprecipitation of bands compatible
with the corresponding CFP-tagged form, together with an endogenous
PIST band.
We next tested the different isoforms for their capability to
bind KV10.1. Precipitation of KV10.1_BBS out of stably express-
ing HEK293 cells was able to co-precipitate over-expressed CFP-
tagged PIST and nPIST (Figure 3B). In comparison to the long
forms, co-precipitation of the tagged short isoform CFP_nsPIST
was much less evident in this assay (Figure 3B). Since the short
forms lack most of the PDZ domain, these data suggest an
involvement of the PDZ domain of PIST in KV10.1 binding.
Interestingly, overexpression of the long isoforms resulted in
higher intensity in bands compatible with the endogenous full-
length PIST, while the shorter isoform rendered more intense
bands corresponding to short isoforms (Figure 3B).
PIST INFLUENCES CURRENTSMEDIATED BY KV10.1, BUT NOT BY
KV10.2
We next tested if there are functional consequences of the interac-
tion between PIST and KV10.1. As a model we used voltage clamp
recordings in the Xenopus oocyte expression system and checked
if the overexpression of any PIST isoform can influence KV10.1-
mediated current. Regardless of the concomitant overexpression
of human PIST isoforms, macroscopic KV10.1 currents showed
very similar voltage dependence (Figure 4); in fact, the current-
voltage relationship could be fitted using the same parameters
used for KV10.1 alone (Figure 4B). We did not appreciate dif-
ferences in kinetics, and the main properties of KV10.1 were
conserved in the presence of PIST isoforms (not shown).
The total current amplitude, however, was influenced by PIST
expression (Figures 4A,C). Over-expression of PIST was able
to nearly double the amplitude of KV10.1 mediated current
(189 ± 33% of control levels). The difference was more signifi-
cant the more depolarized the stimulus (reaching p < 0.0001 at
+80mV and above). Injection of nPIST and nsPIST did not affect
the amplitude. These observations are compatible with an influ-
ence of PIST on the membrane expression of KV10.1, similar to
the one described for CFTR (Cheng et al., 2005). In the presence
of PDZ and coiled-coil domain, the amplitude of KV10.1 currents
was increased. We observed no functional interaction with the
insertion in the coiled-coil of “n” forms.
We previously stated that very poor and irregular expres-
sion of sPIST did not allow us to document physical interaction
between this isoform and KV10.1. However, since experiments in
oocytes do not depend on transfection or transcription, which
is performed in vitro previous to oocyte injection, we also tested
if injection of synthetic cRNA encoding for sPIST affects the
amplitude of the KV10.1-mediated current. Surprisingly, sPIST
coinjection induced a reduction in current amplitude to 55 ± 4%
of control levels. Although they had opposite effects, coinjection
of a mixture of PIST and sPIST together with KV10.1, did not
results on compensation of the effects, but rather sPIST showed
a dominant-negative effect, in such a way that the current was
reduced to the same extent as when sPIST was injected alone
(Figure 4D).
A Golgi-resident protein like PIST might have a general effect
on the expression level of ion channels in the oocyte expression
system, enhancing transport mechanism toward the membrane.
As a measure for the specificity of our observations, we tested the
effect of PIST overexpression on KV10.2, the closest relative of
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KV10.1. PIST overexpression did not change voltage-dependence
or kinetic parameters of KV10.2. In contrast to KV10.1,
there was also no change in current amplitudes of KV10.2-
mediated currents (Figure 4E), pointing toward a highly specific
effect of PIST expression on KV10.1, but not KV10.2 current
amplitude.
CELLULAR DISTRIBUTION OF KV10.1 CHANGES IN RESPONSE TO PIST
OVEREXPRESSION
Having shown that PIST is able to interact physically and func-
tionally with KV10.1, we next asked if both proteins co-localize
in vivo. PIST is reported to reside mainly in the Golgi appara-
tus, depending on at least one coiled-coil region, but can also
be pulled to the membrane in co-expression with its interaction
partners (Charest et al., 2001; Yao et al., 2001; Wente et al., 2005b).
To perform subcellular localization studies, we used CFP-tagged
forms of PIST. As described in the literature, the longer forms of
PIST were mainly located in the Golgi, the neuronal form being
slightly more diffuse (Figures 5, 6A). nsPIST localized to discrete
areas of the Golgi.
Co-expression of a Venus-tagged KV10.1 led to a slight
change in the localization of PIST only, a fraction of which
FIGURE 4 | PIST influences KV10.1 function. (A) Current-voltage
relationship of KV10.1 expressed in Xenopus oocytes with or without PIST.
Current amplitudes were significantly larger in oocytes coinjected with PIST
(N = 4; ∗∗p < 0.01; ∗∗∗p < 0.001). (B) After normalization to the current
value at +100mV, the current-voltage plots overlap, indicating that the
voltage-dependence of the channel is not altered by PIST. (C) Relative
current amplitude (at + 80mV) in oocytes co-expressing PIST isoforms with
respect to KV10.1 alone (N = 19). PIST (N = 18) induced a significant
increase (p < 0.05), while nPIST (N = 10) and nsPIST (n = 14) did not alter
current amplitude. (D) Co-injection of sPIST reduced the current amplitude
both in the absence (N = 8) and in the presence (N = 8) of PIST. (E) PIST
expression did not affect KV10.2 current amplitude.
showed expression at the membrane; this also resulted in a
clearer membrane localization of KV10.1 itself. Expressed alone,
KV10.1_Venus showed a typical distribution of this ion channel
in the cell, where most KV10.1 stays intracellular and only weak
expression can be seen at the membrane (Figure 6B). PIST coex-
pression led to peripheral venus signal compatible with increased
channel localization at the plasma membrane (Figures 6C,D).
Overexpression of nPIST as well as its short form nsPIST did not
change KV10.1 localization in the cell (not shown). This data fur-
ther supports the idea that a trafficking effect of PIST might be
involved in the regulation of macroscopic current amplitude.
PIST CHANGESMEMBRANE EXPRESSION OF KV10.1
To get more quantitative data we made use of another sys-
tem recently established in our lab, which is based on KV10.1
bearing an α-bungarotoxin (BTX) binding site between trans-
membrane segments 3 and 4 (KV10.1_BBS). Different labeling
techniques with an α-BTX-biotin conjugate allow to distin-
guish between whole cell, membrane bound and internalized
KV10.1 out of stably expressing cells and to quantify this dif-
ferent fractions via ELISA (Kohl et al., 2011). Specific labeling
of membrane KV10.1_BBS is possible by incubating intact cells
stably expressing KV10.1_BBS at low temperature (to avoid inter-
nalization) with an α-BTX-biotin conjugate. Quantification of
FIGURE 5 | Single confocal slices of cells expressing CFP-tagged PIST
isoforms (blue). The Golgi apparatus was stained with BODIPY-C5
ceramide (red). Scale bar, 10μm.
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FIGURE 6 | Cellular distribution of KV10.1_Venus and CFP-tagged PIST.
CFP-PIST, when expressed alone (A), reproduced from Figure 5, gave a
diffuse distribution with preferential location to the Golgi (stained in red).
Overexpressed KV10.1 showed a preferentially intracellular distribution (B).
When co-expressed (C), both CFP-PIST and KV10.1 were detectable at the
cell periphery, compatible with an increase of membrane localization of
both proteins. (D) represents a larger magnification of the area represented
by a white square in the “merged” panel in (C), Scale bar: 10μm.
FIGURE 7 | Over-expression of PIST isoforms differently influences
cellular fractions of KV10.1_BBS. Different labeling protocols allowed
distinguishing between whole cell, membrane bound and internalized
KV10.1_BBS by ELISA (see Materials and Methods). The fraction of
membrane bound KV10.1_BBS, labeled on living cells, was clearly enriched
by expression of PIST but not of the other isoforms (N = 3; ∗∗∗p < 0.001).
this fraction of membrane bound KV10.1_BBS revealed that
the overexpression of CFP-tagged PIST can indeed increase sur-
face KV10.1_BBS to 214 ± 28% of control levels (Figure 7).
In agreement with findings in the oocyte expression system,
the neuronal forms of PIST (nPIST and nsPIST) did not
have any effect on membrane KV10.1_BBS, as values were not
different (94 ± 15% nPIST, 91 ± 16% nsPIST) from control
levels.
Both increased expression levels and increased stability of
plasma membrane KV10.1_BBS could explain this observa-
tion. To distinguish between both possibilities, we examined
the effect of overexpressing PIST isoforms on whole cell
KV10.1_BBS, labeled after lysis of the cells. Neither isoform
of PIST had an effect on the amount of total KV10.1_BBS
(Figure 7), giving values of 96 ± 5% (PIST), 92 ± 3% (nsPIST)
or 102 ± 9% (nPIST) in comparison to control levels, indicat-
ing that neither isoform of PIST affect total expression levels
of KV10.1_BBS. Therefore, they may be involved in the trans-
port of this voltage gated ion channel to and from the plasma
membrane.
The KV10.1_BBS system easily allows for the quantification
of internalized KV10.1_BBS within a given time frame (Kohl
et al., 2011). For this, we incubated living cells with α-BTX-
biotin conjugate at 37◦C and allowed internalization for one hour.
Removal of the label of membrane-bound KV10.1_BBS by acid
wash afterwards leaves only the internalized labeled KV10.1_BBS
for quantification. Interestingly, neither isoform had an effect on
the total amount of internalized KV10.1_BBS (PIST 90 ± 9%,
nsPIST 92 ± 13%, nPIST 98 ± 8%). As membrane expression of
KV10.1_BBS is clearly increased in response to PIST overexpres-
sion (Figure 7), one would expect more channels internalized if
the rate of internalization is not affected by this protein.
DISCUSSION
In this study we identified PIST as a binding partner of KV10.1
and cloned two new isoforms of PIST. The novel variants lack
a significant fraction of the PDZ domain and are expressed in
all tissues examined, although with lower abundance than their
respective longer forms. The shorter form was also detected at
the protein level in HEK293 cells (Figure 3). The new isoforms
correspond to skipping of exon 6 in the human gene, encod-
ing for most of the PDZ domain. Interaction of KV10.1 and
PIST appears to require the PDZ domain of the latter, since
deletion of this domain reduced binding in pull-down assays.
On the channel side, the C-terminus of the protein was the
part that showed interaction with PIST in a yeast two-hybrid
screen, and therefore is a probable mediator of the interaction.
However, the interaction might need an additional binding part-
ners, because pull down experiments using recombinant purified
proteins (KV10.1 C-terminus and PIST) were unsuccessful (not
shown).
We found KV10.1-mediated current to be influenced by the
overexpression of PIST in Xenopus oocytes. This effect is appar-
ently not due to changes in the electrophysiological properties
of KV10.1 but rather due to a change in the surface expression
of the channel, which was clearly enhanced by PIST as indicated
by surface-labeling experiments. Binding of endogenous PIST
was enhanced by overexpression of CFP-tagged PIST, leading to
the idea that binding gives a positive feedback that stabilizes or
improves association of both proteins in vivo.
Forced expression of the short isoform of PIST (sPIST) acts as
a dominant negative in Xenopus oocytes, in the sense that leads
to reduction of functional expression of KV10.1 (Figure 4D).
These data are in good agreement with previous observations
regarding the interaction of PIST with AMPA receptors (Cuadra
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et al., 2004). Although binding of several proteins to the coiled-
coil region of PIST is reported, functional consequences have
only been described through interaction with the PDZ domain
(Cuadra et al., 2004; He et al., 2004; Cheng et al., 2005; Wente
et al., 2005a; Xu et al., 2010). Deletion of the PDZ domain
results in a dominant negative effect in AMPA receptor clustering
(Cuadra et al., 2004). This led to the hypothesis that the short
forms of PISTmight serve as negative regulators of PIST function,
in good agreement with our observations in oocytes.
nPIST, which differs from PIST by an insertion of eight
amino acids, was not able to regulate KV10.1 in our model sys-
tems. Since the insertion occurs in the coiled-coil region, the
lack of regulation by nPIST indicates that, although the phys-
ical interaction with KV10.1 depends on the PDZ domain, the
functional effect requires additionally the coiled-coil region of
PIST. This raises the question if and how the surface expres-
sion of KV10.1, which is normally expressed exclusively in the
central nervous system (Pardo et al., 1999), is controlled by
nPIST and PIST in vivo. We cannot exclude from our data that
nPIST might also control surface levels of KV10.1 in vivo because,
as already mentioned, it is likely that additional partners are
required the functional interaction of nPIST and KV10.1. These
additional factor(s) could be different for nPIST and PIST, and
its (their) absence might preclude an nPIST-mediated effect in
our systems. Our results point to an at least much more effi-
cient influence of PIST compared to nPIST in positively affecting
KV10.1 surface expression. This implies that, in tumors out-
side the brain, the surface expression of ectopically expressed
KV10.1 would be additionally boosted by the expression of
PIST.
From our data, we can only speculate about the mecha-
nism by which PIST can influence the surface expression of
KV10.1. However, we can exclude mechanisms involving an over-
all increased amount of KV10.1, induced either by enhanced
synthesis or decreased degradation of the ion channel, since we
observed no changes in total KV10.1 in cells overexpressing PIST.
Although there are apparently more active channels at the
membrane, the amount of internalized KV10.1 is not altered by
overexpression of PIST, indicating that PIST induces a more effi-
cient transport of KV10.1 to the plasma membrane. However,
this interpretation might be an oversimplification, because it
would require that the amount of KV10.1 channels at the plasma
membrane does not influence the rate of internalization, which
is counterintuitive. Trafficking of KV10.1 is not yet completely
understood. We have recently described Rabaptin 5 (RABEP1)
as an interaction partner of KV10.1, linking this ion channel
to early endosomes (Ninkovic et al., 2012). As an early event
in the maturation and function of early endosomes Rabaptin 5
is able to bind and stabilize the GTP form Rab5, which then
recruits effector proteins (Stenmark et al., 1995; Lippe et al.,
2001). PIST interacts with Syntaxin 6, a member of the Syntaxin
family of SNAREs that is also a Rab5 effector (Charest et al.,
2001). Syntaxin 6, together with Syntaxin 13, VTI1a (Vps10p tail
interactor 1) and VAMP4 were identified as the SNARE machin-
ery involved in homotypic fusion of early endosomes to where
it is recruited by direct binding of early endosomal antigen-1
(Simonsen et al., 1999; Brandhorst et al., 2006; Zwilling et al.,
2007). PIST could therefore interfere with this machinery to
block KV10.1 internalization. Inhibition of internalization pro-
cesses by overexpression of a dominant-negative point mutant of
Rab5(S34N), shown to block endocytosis (Li and Stahl, 1993),
drastically reduced the amount of internalized KV10.1, but was
not able to increase its surface expression significantly (data not
shown). If PIST only impairs endocytosis of KV10.1, we therefore
would not expect such a high increase in its surface expression as
seen here.
PIST is also involved in sorting mechanisms, facilitating the
trafficking of CFTR to lysosomes when over-expressed (Cheng
et al., 2002, 2004, 2005; Gentzsch et al., 2003). Moreover, the
Rho GTPase TC10 can bind to PIST and modulate this effect
(Neudauer et al., 2001; Cheng et al., 2005). Another example of
PIST function is the enhancement of synaptic clustering of AMPA
receptors in hippocampal neurons in response to overexpression
of the neuronal form of PIST (Cuadra et al., 2004). Deletion of
the PDZ domain served as dominant negative form of nPIST
clearly reducing AMPA clustering at the membrane (Cuadra et al.,
2004). Endosomal sorting of AMPA receptors beginning in early
endosomes towards either recycling or late endosomes is well doc-
umented to be a main process in long term synaptic plasticity
in hippocampal neurons [reviewed in Hanley (2010)]. Therefore
nPIST, like PIST for CFTR, might be involved in sorting processes
for AMPA receptors, favoring recycling.
A similar effect might be postulated for the KV10.1-PIST inter-
action. PIST may serve as a molecular switch to control the
fate of the channel after internalization in early endosomes by
enhancing its recycling. This would lead to an increased mem-
brane expression of the channel, while the amount of internalized
KV10.1 would be reduced, leading in our case to equal amounts
of internalized KV10.1 despite drastic changes in the membrane
expression. Another interaction partner of PIST might regulate
this process by binding to the coiled-coil region of PIST, like TC10
does for CFTR (Cheng et al., 2005). Candidate proteins for this
interaction are small Rho GTPases like TC10 or Rab proteins,
as Rab6a was shown to bind PIST (Bergbrede et al., 2009). The
insertion of eight amino acids in the neuronal form of PIST lies
in the region putatively responsible for this interaction, leading
to the hypothesis that the isoforms can be regulated by different
binding partners. These binding partners might decide if a pro-
tein bound to the PDZ domain of PIST is sorted to lysosomes
or to a recycling process. The lack of the right binding partner
for nPIST in our systems would explain why we observed a dif-
ferent behavior of PIST and nPIST although both are able to
bind KV10.1 in pull down assays. The shorter forms of PIST may
serve as a dominant negative variant, whose expression controls
PIST function in vivo by trapping the binding partners of the
coiled-coil region without linking them to effected proteins like
KV10.1.
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